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Background: The monkey malaria parasite Plasmodium knowlesi is now recognized as the fifth species of
Plasmodium that can cause human malaria. Like the region II of the Duffy binding protein of P. vivax (PvDBPII), the
region II of the P. knowlesi Duffy binding protein (PkDBPαII) plays an essential role in the parasite’s invasion into the
host’s erythrocyte. Numerous polymorphism studies have been carried out on PvDBPII, but none has been reported
on PkDBPαII. In this study, the genetic diversity, haplotyes and allele groups of PkDBPαII of P. knowlesi clinical
isolates from Peninsular Malaysia were investigated.
Methods: Blood samples from 20 knowlesi malaria patients and 2 wild monkeys (Macaca fascicularis) were used.
These samples were collected between 2010 and 2012. The PkDBPαII region of the isolates was amplified by PCR,
cloned into Escherichia coli, and sequenced. The genetic diversity, natural selection and haplotypes of PkDBPαII
were analysed using MEGA5 and DnaSP ver. 5.10.00 programmes.
Results: Fifty-three PkDBPαII sequences from human infections and 6 from monkeys were obtained. Comparison at the
nucleotide level against P. knowlesi strain H as reference sequence showed 52 synonymous and 76 nonsynonymous
mutations. Analysis on the rate of these mutations indicated that PkDBPαII was under purifying (negative) selection. At
the amino acid level, 36 different PkDBPαII haplotypes were identified. Twelve of the 20 human and 1 monkey blood
samples had mixed haplotype infections. These haplotypes were clustered into 2 distinct allele groups. The majority of
the haplotypes clustered into the large dominant group.
Conclusions: Our present study is the first to report the genetic diversity and natural selection of PkDBPαII. Hence, the
haplotypes described in this report can be considered as novel. Although a high level of genetic diversity was observed,
the PkDBPαII appeared to be under purifying selection. The distribution of the haplotypes was skewed, with one
dominant major and one minor group. Future study should investigate PkDBPαII of P. knowlesi from Borneo, which
hitherto has recorded the highest number of human knowlesi malaria.
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Malaria is caused by blood protozoa of the genus Plasmo-
dium. Historically, four species of Plasmodium are known
to cause human malaria: Plasmodium falciparum, P. vivax,
P. malariae, and P. ovale. However, about a decade ago, P.
knowlesi, a malaria parasite of macaque monkeys, was* Correspondence: fongmy@um.edu.my
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unless otherwise stated.reported to cause a large number of human infections in
Sarawak, Borneo Island [1]. Since then, human knowlesi
malaria has been reported in other parts of Borneo Island,
Peninsular Malaysia, and in many other countries in
Southeast Asia [2]. Imported knowlesi malaria cases have
been reported in European countries and Japan due to eco-
tourism programs to the forested areas of Southeast Asia.
Now, P. knowlesi is recognised as the fifth species of
Plasmodium that can cause human malaria.
Invasion of a malaria parasite into its host erythrocyte
depends on the interaction between the parasite’std. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Date and origin of human and monkey blood






(State in Peninsular Malaysia)
ANU Feb 2012 Kelantan
AZL Jun 2011 Perak
CHO Oct 2010 Pahang
GAN Oct 2011 Selangor
HAI Feb 2012 Kelantan
HAN Feb 2012 Kelantan
HEN Feb 2012 Kelantan
IZA Aug 2010 Selangor
JUN Feb 2012 Kelantan
MAD Aug 2010 Negeri Sembilan
MAH Aug 2011 Selangor
MEL Feb 2012 Kelantan
NGO Oct 2010 Perak
OTH Feb 2012 Kelantan
RAU Feb 2012 Kelantan
SUP Feb 2012 Kelantan
SYA Feb 2012 Kelantan
UM0001 Jan 2012 Selangor
UM0002 Feb 2012 Kelantan
UM0004 Apr 2012 Selangor
Monkey566 Oct 2010 Negeri Sembilan
Monkey569 Oct 2010 Pahang
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of the erythrocyte. Plasmodium vivax and P. knowlesi
use the Duffy blood group antigen as a receptor to in-
vade erythrocytes [3]. The Duffy binding proteins of P.
vivax (PvDBP) and P. knowlesi (PkDBP) are located on
their merozoites. PvDBP and PkDBP are members of the
erythrocyte-binding protein family which also includes
the P. falciparum EBA-175 [4]. PvDBP and PkDBP are
large proteins and can be divided into seven regions
(I-VII). Region II contains the critical motifs for binding
to the erythrocyte Duffy antigen.
PkDBP is encoded by an α-gene and therefore is more
specifically known as PkDBPα. This is to distinguish it from
two other highly homologous proteins in P. knowlesi – β
and γ. Region II of the β and γ proteins have different bind-
ing specificities compared to PkDBPα. Region II of the β
and γ proteins binds to rhesus erythrocytes but does not
bind to Duffy antigen of human erythrocytes [5].
PvDBP has been suggested to be an important vaccine
candidate antigen against vivax malaria because it elicits
strong immune responses in humans. Design of vaccine
against vivax malaria must take into consideration the
nature and genetic polymorphism of PvDBP. Region II
of PvDBP (denoted as PvDBPII) in P. vivax isolates from
different geographical regions such as Colombia, South
Korea, Papua New Guinea, Thailand, Iran and Myanmar
has been shown to be highly polymorphic, and numer-
ous PvDBPII haplotypes and allele groups have been
identified [6-11].
It has been observed that antibodies raised against
PkDBPαII could inhibit P. knowlesi invasion of human
and rhesus erythrocytes in vitro [12]. Therefore, like
PvDBPII for vivax malaria, PkDBPαII may also be a can-
didate vaccine antigen against knowlesi malaria. Whilst
many polymorphism studies on PvDBPII have been car-
ried out, hitherto, none has been reported for PkDBPαII.
In this report, we present our findings on genetic diver-
sity, haplotyes and allele groups of PkDBPαII in P. know-
lesi clinical isolates from Peninsular Malaysia.
Methods
Blood samples
Human blood samples used in this study were collected
from 20 patients who were infected with Plasmodium
knowlesi at the University of Malaya Medical Centre and
several private clinics in Peninsular Malaysia. Two blood
samples from P. knowlesi-infected wild monkeys (Macaca
fascicularis) were provided by the Wildlife Department of
Federal Territory, Peninsular Malaysia. These blood sam-
ples were collected between 2010 and 2012 from various
states in Peninsular Malaysia (Table 1). Confirmation of
P. knowlesi infection in all the samples was carried out by
microscopic examination of Giemsa-stained thin and thick
blood smears and polymerase chain reaction. Ethicalapprovals for the use of human and monkey blood samples
in this study were granted by the University of Malaya
Medical Centre Ethic Committee and (MEC No. 817.18)
and the University of Malaya Animal Care and Use Com-
mittee (PAR/19/02/2013/AA[R]).
Extraction of DNA
Total DNA of the P. knowlesi was extracted from each
blood sample using the QIAGEN Blood DNA Extraction
kit (QIAGEN, Hilden, Germany). In each extraction,
100 μl of blood was used. The extracted DNA was sus-
pended in water to a final volume of 50 μl.
PCR, cloning and sequencing of the PkDBPαII
The PkDBPαII was amplified by nested PCR using oligo-
nucleotide primers Pkα-DBP-F1: 5′-CGCATTTTGAA
GGAATCCAC-3′ and Pkα-DBP-R1: 5′-TGCTAGACT
TACCTTCACCT-3′ for nest 1. The primers for the nest
2 reaction were Pkα-DBP-F: 5′-TCCTCAAAAGGCGG
TGACCATCC-3′ and Pkα-DBP-R: 5′-ACTGGCTGCC
TTAGATTCAACACCA-3′. Cycling conditions for nest
1 were as follows: 95°C for 4 mins, 30 cycles at 95°C for





















Figure 1 Nucleotide polymorphism in the PkDBPαII of P. knowlesi. Sliding window plot of number of polymorphic sites (S) along the
PkDBPαII, generated by using DnaSP ver. 5.10.00 with a window length of 100 bp and step size of 25 bp.
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nest 2 was performed using the following cycling profile:
95°C for 4 mins, 30 cycles at 95°C for 30 secs, 56°C for
30 secs, and 72°C for 90 secs, followed by a 10 min ex-
tension at 72°C. The PCR product with an expected size
of 1053 bp was analyzed on a 1% agarose gel.Figure 2 Amino acid sequence polymorphism in PkDBPαII. Polymorph
residues identical to those of the reference sequence, strain H (haplotype 1
changes are marked in blue and red, respectively. Total number of sequenPurification of PCR products and DNA cloning
PCR products were purified by QIAquick PCR purifica-
tion Kit (QIAGEN, Hilden, Germany) following the
manufacturer’s instructions. The purified PCR products
were then ligated into cloning vector pGEM-T® (Pro-
mega Corp., USA) and transformed into Escherichia coliic amino acid residues are listed for each haplotype. Amino acid
), are marked in yellow. Monomorphic and dimorphic amino acid
ces for each haplotype is listed in the right panel.




AZL H9, H10, H11
CHO H3, H8




IZA H2, H3, H4
JUN H15
MAD H24, H25, H26, H27, H28, H29
MAH H2, H33
MEL H12, H13, H14
NGO H2
OTH H2, H16




UM0002 H2, H22, H23
UM0004 H32
Monkey566 H2
Monkey569 H34, H35, H36
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the PkDBPαII fragment were sent to a commercial la-
boratory for DNA sequencing. To detect the possibility
of multiple haplotypes infecting a patient or monkey,
plasmids from 4–6 recombinant clones from each trans-
formation mixture were sequenced.
Analysis of PkDBPαII sequences
Alignment of 60 sequences of PkDBPαII [53 of human
origin, 6 of monkey origin, 1 reference strain (strain H,
GenBank Accession No. M90466)] were performed
using CLUSTAL-Omega programme which was available
on-line (http://www.ebi.ac.uk/Tools/msa/clustalo). Both
nucleotide and the deduced amino acid sequences were
aligned and analysed. Phylogenetic tree was constructed
using the Neighbour Joining method described in
MEGA5 [13]. In constructing the phylogenetic tree,
bootstrap replicates of 1000 were used to test the ro-
bustness of the tree.
PkDBPαII sequence polymorphism analysis
DnaSP ver. 5.10.00 [14] was used to perform polymorphism
analysis on the 60 PkDBPαII sequences. Information such
as the number of segregating sites (S), haplotype diversity
(Hd), nucleotide diversity (π), and average number of pair-
wise nucleotide differences within the population (K) were
generated. The π was also calculated on a sliding window
of 100 bases, with a step size of 25 bp to estimate the step-
wise diversity across PkDBPαII. The rates of synonymous
(Ks) and non-synonymous (Kn) substitutions were esti-
mated and compared by the Z-test (P < 0.05) in MEGA5
using the Nei and Gojobori’s method [15] with the Jukes
and Cantor correction. In the case of purifying (negative)
selection, mutations are usually not advantageous so that
Kn will be less than Ks (Kn/Ks < 1). However, in positive se-
lection, non-synonymous mutations can be advantageous
and Kn will exceed Ks (Kn/Ks > 1). For testing the neutral
theory of evolution, Tajima’s D [16] and Fu and Li’s D and F
[17] tests was carried out using DnaSP 5.10.00. In the Fu
and Li’s tests, P. vivax PvDBPII (GenBank Accession No.
M90466) was used as outgroup.
Results
Nested PCR amplification on the human and monkey
blood samples isolates produced DNA fragments of 1053
base pairs. The sequence of each fragment was trimmed to
921 bp, based on the PkDBPαII region identified by Singh
et al. [18]. This trimmed sequence encoded an amino acid
sequence of 307 in length. A final total of 59 sequences
(GenBank Accession No. KC597079 – KC597137) were
obtained.
DNA sequence analyses were conducted to determine
nucleotide diversity and genetic differentiation. The aver-
age number of pairwise nucleotide differences (K) for thePkDBPαII was 11.736. The overall haplotype diversity
(Hd) and nucleotide diversity (π) for the 60 PkDBPαII se-
quences were 0.986 ± 0.008 and 0.013 ± 0.002, respectively.
Detailed analysis of π, with a sliding window plot (window
length 100 bp, step size 25 bp), revealed diversity ranged
from 0.003 to 0.034. The highest peak of nucleotide diver-
sity was within nucleotide positions 600–750, whereas the
most conserved region was within nucleotide positions
260–360 (Figure 1).
Analysis and comparison at the nucleotide level against
P. knowlesi strain H as reference sequence showed muta-
tions at 128 positions among the Peninsular Malaysia iso-
lates. Fifty-two of these mutations were synonymous and
76 were nonsynonymous. To determine whether natural
selection contributed to the diversity in the PkDBPαII, the
rate of nonsynonymous (Kn) to synonymous mutations
(Ks) was estimated. Kn (0.00952) was found lower than Ks
(0.00278) and the Kn/Ks ratio was 0.347, suggesting that
purifying (negative) selection may be occurring in the
PkDBPαII. Similarly, the Z test (Ks >Kn; P < 0.05) also
indicated purifying selection on PkDBPαII. In the tests of
departure of neutrality of selection, the Tajima’s D statis-
tics was −2.085 (P < 0.05), indicating expansion in
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supported by the Fu and Li’s D and F tests statistics
(−3.772 and −3.756, respectively; P < 0.05).
Comparison at the amino acid level revealed high
polymorphism across the entire PkDBPαII of the isolates
(Figure 2). Among the 70 polymorphic sites, 66 showed
monomorphic mutation (changed into one amino acid-
type) and 4 showed dimorphic mutation [changed into two
amino acid types: 221 (Q, T), 302 (N, Y), 303 (F, S), 307
(A, I)]. The amino acid sequences could be categorised into
36 different haplotypes (H1-H36) with haplotype 2 having
the highest frequency (19/60). Twelve of the 20 human and
1 monkey blood samples had mixed haplotype infections
(Table 2). Phylogenetic tree analysis revealed that the haplo-

























Figure 3 Phylogenetic tree of PkDBPαII haplotypes. Neighbour-Joining
Plasmodium vivax PvDBPII was used as outgroup. Numbers at nodes indicaDiscussion
The DBP of P. vivax and P. knowlesi play an essential
role in erythrocyte invasion of the parasites by mediating
irreversible binding with its corresponding receptor, the
Duffy protein receptor for chemokines (DARC) on the
surface of erythrocytes [19]. The DBP elicits strong im-
mune responses in humans and therefore has been sug-
gested to be an important vaccine candidate antigen
[12,20]. The critical erythrocyte-binding motif of DBP
has been identified to be located in region II of the pro-
tein. The P. vivax PvDBP has been observed to have a
high degree of genetic polymorphism, and most of the
polymorphism is located in region II. Although the cyst-
eine and some hydrophobic amino acid residues in
PvDBPII are conserved in P. vivax populations from dif-






































method was used to construct the tree, which contains 36 haplotypes.
te percentage support of 1000 bootstrap replicates.
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ther been revealed that PvDBPII undergoes positive nat-
ural pressure which results in allelic variation as a
mechanism for immune evasion. On the other hand,
despite the emerging importance of P. knowlesi as a hu-
man pathogen, no study has thus far been carried out on
PkDBPαII. Our present study is the first to report the di-
versity and natural selection of PkDBPαII.
The PkDBPαII analysed in this study is based on the
region defined by Singh et al. [18] using structural biol-
ogy analysis. In their analysis, twelve C residues (posi-
tions 16, 29, 36, 45, 99, 176, 214, 226, 231, 235, 304,
306), which form six disulphide bridges, have been sug-
gested to be involved in the folding of PkDBPαII for
interaction with DARC. Multiple alignment of the 60
PkDBPαII amino acid sequences (Additional file 1) in
our study revealed that these 12 residues were highly
conserved. Apart from these conserved C residues, the
Y94, N95, K96, R103, L168 and I175 residues are re-
quired for recognition of DARC on human erythrocytes
[18]. Again, our multiple sequence alignment showed
high conservation of these residues in the PkDBPαII. In
fact, Y94, N95, K96 and R103 fall within the most con-
served region in the PkDBPαII (nucleotide positions
260–360 in the gene, Figure 1).
The PkDBPαII (K = 11.736; Hd = 0.986; π = 0.01274) in
Peninsular Malaysia seemed to be more diverse than
P. vivax PvDBPII in some neighbour countries, such as
Myanmar (K = 7.851; Hd = 0.875; π = 0.00790), Korea (K =
2.878; Hd = 0.775; π = 0.00299) and Sri Lanka (Hd = 0.922;
π = 0.00982) [7,11,25]. Generally, high levels of genetic di-
versity in malaria parasite surface antigens are attributed to
positive natural selection, for example, by the host immune
system [26]. Positive selection has been reported in
PvDBPII of isolates in Myanmar, Korea, Sri Lanka and
Thailand [7,9,11,25]. On the contrary, the PkDBPαII in
Peninsular Malaysia was found to be under purifying (nega-
tive) selection. The reason for this finding is unclear, but
may be associated with the host of the parasite. For ex-
ample, it has been reported that the rhoptry-associated pro-
tein 1 (RAP-1) antigen of non-human primate malarial
parasites (P. knowlesi, P. cynomolgi, P. inui and P. fieldi)
showed evidence for negative selection, which was not
found in two human malarial parasites (P. falciparum, P.
vivax) [27]. Another possible reason for the purifying selec-
tion on PkDBPαII is population expansion of P. knowlesi,
as evident by the Tajima’s D statistics. In Peninsular
Malaysia, deforestation in many areas has increased mon-
key and forest dwelling Anopheles vector contact to human.
The expansion of monkey and vector populations and their
ecological niches into human habitation may therefore re-
sult in the population expansion of P. knowlesi [28].
Phylogenetic studies on P. vivax isolates based on
PvDBPII revealed the occurrence of multiple haplotypesin a geographical location, and these haplotypes could
be categorized into several allele groups. For example,
25 haplotypes from Thailand were organized into 5
groups [9]. In Papua New Guinea, 27 haplotypes clus-
tered into 3 dominant groups [9], whereas in Korea, 13
haplotypes were clustered into 3 groups [7]. Our study
revealed the occurrence of 2 distinct allele groups of
PkDBPαII in Peninsular Malaysia (Figure 3). Interest-
ingly, allele group I was more dominant as it contained
the majority (30/36) of the haplotypes. The minor allele
group II had only 6 haplotypes. Two monkey blood sam-
ples were included in this study but all haplotypes from
the monkeys were grouped in allele group I. The refer-
ence strain H, which was isolated in 1965 in Peninsular
Malaysia from the first reported case of human P. know-
lesi infection [29], was also grouped in allele group I.
This shows that despite temporal separation of almost
50 years between strain H and the recent isolates of this
study, no major genetic differences had occurred in the
PkDBPαII.
Conclusions
Our present study is the first to report the genetic diver-
sity and natural selection of PkDBPαII. Hence, the hap-
lotypes described in this report can be considered as
novel. Although a high level of genetic diversity was ob-
served, the PkDBPαII appeared to be under purifying
(negative) selection. Two allele groups of haplotype were
obtained. However, the distribution was skewed, in
which majority of the haplotypes clustered in a large
dominant group. Our study was carried out on Peninsu-
lar Malaysia isolates only. Therefore, future study should
investigate PkDBPαII of P. knowlesi from Borneo, which
hitherto has recorded the highest number of human
knowlesi malaria.
Additional file
Additional file 1: Full amino acid sequence alignment of PkDBPαII.
Amino acid residues identical to those of the reference sequence (strain
H), are indicated by dots. The twelve conserved cysteine (C) residues are
marked in yellow. The conserved Y94, N95, K96, R103, L168 and I175
residues required for recognition of DARC on human erythrocytes are
highlighted in green.
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